Two years have passed since the US Supreme Court鈥檚 decision in Dobbs vs Jackson Women鈥檚 Health to overturn the constitutional protection for abortion rights. With President-elect Donald Trump set to return to the White House in January 2025, the uncertainty and fears around these rights have been heightened.
explores the ethical, legal, and practical implications the US abortion restrictions on those involved in clinical trials, given the restrictions in some states may potentially expose trial sponsors to litigation.聽
Also in this issue, to thwart activist investor Starboard, which took a $1bn stake in and challenged the company’s leadership in pursuit of a turnaround.聽 Additionally, a looks at how a recent investment by obesity and diabetes drug maker Eli Lilly in the UK may play out.
This month’s edition also includes a , highlighting the key pharma industry events to look out for as we head into 2025 along with a look back at major events in 2024.
for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
